Author(s):
Tri Widiandani, Delis Susilawati, Mohammad Rizki Fadhil Pratama, Bambang Tri Purwanto, Siswandono, Farida Ifadotunnikmah
Email(s):
tri-w@ff.unair.ac.id
DOI:
10.52711/0974-360X.2025.00171 
Address:
Tri Widiandani1,4*, Delis Susilawati2, Mohammad Rizki Fadhil Pratama3, Bambang Tri Purwanto1,4, Siswandono1,4, Farida Ifadotunnikmah1
1Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya 60115, Indonesia.
2Master Program of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya 60115, Indonesia.
3Doctoral Program of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya 60115, Indonesia.
4Research Group of Drug Development, Faculty of Pharmacy, Universitas Airlangga, Surabaya 60115 Indonesia.
*Corresponding Author
Published In:
Volume - 18,
Issue - 3,
Year - 2025
ABSTRACT:
Breast cancer is currently one of the most common causes of death in women all over the world. In breast cancer, the proliferation and invasiveness of cancer cells are primarily regulated by hormone receptor-mediated signalling, including estrogen, progesterone, and human epidermal growth factor receptors. The study aims to conduct an in silico investigation using molecular docking and molecular dynamic simulation, as well as to determine the cytotoxicity activity and selectivity index (SI) of 4-methyl-3-benzoyl allylthiourea as an anti-breast cancer agent. Molecular docking was conducted by using the MOE 2022 program to predict the anticancer with three targeted proteins: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2). Molecular dynamics simulation was performed by AMBER 20 to investigate the binding affinity of 4-methyl-3-benzoyl allylthiourea on the selected targets with RMSD, RMSF, and MM-GBSA parameters. The cytotoxic activity was performed using the MTT method against T47D and MCF7/HER2 breast cancer cells. The selectivity of the compound was tested by the same method on normal Vero. Results showed the highest binding affinity of 4-methyl-3-benzoyl allylthiourea to ER, followed by PR and HER2 receptors with S scores of -6.287, -7.127, and -6.855 kcal/mol, respectively. The molecular dynamics simulation showed that interaction between 4-methyl-3-benzoyl allylthiourea and 1E3K is predicted to be the most stable conformation than other receptors. The cytotoxicity test resulted in IC50 in T47D and MCF7/HER2 cells of 296 and 134 µM, respectively. The SI values of 4-methyl-3-benzoyl allylthiourea for T47D and MCF7/HER2 are 2 and 4, respectively. In conclusion, 4-methyl-3-benzoyl allylthiourea has high potential as an anti-breast cancer candidate that acts on the ER, PR, and HER2 receptors. Therefore, it is very promising for further development.
Cite this article:
Tri Widiandani, Delis Susilawati, Mohammad Rizki Fadhil Pratama, Bambang Tri Purwanto, Siswandono, Farida Ifadotunnikmah. The Potency of 4-Methyl-3-Benzoyl Allylthiourea as Anti-Breast Cancer: Molecular Dynamic Simulation, Cytotoxic Activity and its Selectivity Index. Research Journal of Pharmacy and Technology. 2025;18(3):1182-8. doi: 10.52711/0974-360X.2025.00171
Cite(Electronic):
Tri Widiandani, Delis Susilawati, Mohammad Rizki Fadhil Pratama, Bambang Tri Purwanto, Siswandono, Farida Ifadotunnikmah. The Potency of 4-Methyl-3-Benzoyl Allylthiourea as Anti-Breast Cancer: Molecular Dynamic Simulation, Cytotoxic Activity and its Selectivity Index. Research Journal of Pharmacy and Technology. 2025;18(3):1182-8. doi: 10.52711/0974-360X.2025.00171 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-3-32
REFERENCES:
1. Globocan. 2020. Cancer. Global Cancer Observatory 2020, https://gco.iarc.fr/, accessed Februari 30 2023.
2. Gibbs JB, Anticancer drug targets: growth factors and growth factor signaling. Journal of Clinical Investigation. 2000; 105(9). https://doi.org/10.1172/JCI9084
3. Li HQ, Yan T, Ying Y, Shi L, Zhou CF, Zu HL, Synthesis and structure–activity relationships of N-benzyl-N-(X-2-hydroxybenzyl)-N′-phenylureas and thioureas as antitumor agents. Bioorganic and Medicinal Chemistry. 2010; 18(305). https://doi.org/10.1016/j.bmc.2009.10.054
4. Hanaa H. Ahmed, Hadeer A. Aglan, Ghada H. Elsayed, Hebatallah G. Hafez, Emad F. Eskander. Quercetin Offers Chemopreventive Potential against Breast Cancer by Targeting a Network of Signalling Pathways. Research Journal of Pharmacy and Technology. doi: 10.52711/0974-360X.2021.00499
5. Opdam FL, Guchelaar HJ, Beijnen JH, Schellens JH. Lapatinib for advanced or metastatic breast cancer. Oncologist. 2012; 17(4): 536-42. https://doi.org/10.1634/theoncologist.
6. D'Amato V, Raimondo L, Formisano L, Giuliano M, De Placido S, Rosa R, Bianco R. Mechanisms of lapatinib resistance in HER2-driven breast cancer. Cancer Treatment Review. 2015; 41(10): 877-83. https://doi.org/10.1016/j.ctrv.2015.08.001.
7. Wang, YC., Morrison, G., Gillihan, R. et al. Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers - role of estrogen receptor and HER2 reactivation. Breast Cancer Research. 2011; 13(R121). https://doi.org/10.1186/bcr3067.
8. Yang W, Hu Y, Yang YS, Zhang F, Zhang YB, Wang XL, Tang JF, Zhong WQ, Zhu HL, Design, modification and 3D QSAR studies of novel naphthalin-containing pyrazoline derivatives with/without thiourea skeleton as anticancer agents. Bioorganic and Medicinal Chemistry 2013; 21(1050), https://doi.org/10.1134/S1068162016040026
9. Liu W, Zhou J, Zhang T, Zhu H, Qian H, Zhang H, Huang W, Gust H, Bioorganic and Medicinal Chemistry Letters. 2012; 22(8): 2701, https://doi.org/10.1016/j.bmcl.2012.03.002
10. Widiandani T, Siswandono S, Meiyanto E, Anticancer evaluation of N-benzoyl-3-allylthiourea as potential antibreast cancer agent through enhances HER-2 expression. Journal of Advanced Pharmaceutical Technology and Research. 2020; 11(163), http://doi.org/10.4103/japtr.JAPTR_77_20.
11. Young DC, Computational Drug Design, A Guide for Computational and Medicinal Chemists, 2009, New York: John Wiley and Sons
12. Pratama, MRF., Praditapuspa, EN., Kesuma, D., Poerwono, H., Widiandani, T., and Siswodihardjo, S. Boesenbergia Pandurata as an Anti-Breast Cancer Agent: Molecular Docking and ADMET Study. Letters in Drug Design and Discovery 2022; 19(7), 606-626. https://doi.org/10.2174/1570180819666211220111245
13. Widiandani, T., Siswandono, Meiyanto, E., Sulistyowaty, M.I., Purwanto, B.T., Hardjono, S. New N-allylthiourea derivatives: Synthesis, molecular docking and in vitro cytotoxicity studies. Tropical Journal of Pharmaceutical Research. 2018; 17(8): 1607-1613. http://dx.doi.org/10.4314/tjpr.v17i8.20
14. Hardjono, S., Widiandani, T., Purwanto B.T., and Anindi L. Molecular Docking of N-benzoyl-N’-(4-fluorophenyl) thiourea Derivatives as Anticancer Drug Candidate and Their ADMET prediction. Research Journal of Pharmacy and Technology. 2019;12(5). pp.2160-2166. ISSN 0974-3618
15. Agustin, S. L., Widiandani, T., Hardjono, S., and Purwanto, B. T. (2022). QSAR of Acyl pinostrobin derivatives as Anti-breast cancer against HER-2 receptor and their ADMET properties based on in silico Study. Research Journal of Pharmacy and Technology, 15(10): 4641-4648. https://doi.org/10.52711/0974-360X.2022.00779
16. Siswandono, Widyowati R, Suryadi A, Widiandani T, Prismawan D. Molecular modeling, synthesis, and qsar of 5-o-acylpinostrobin derivatives as promising analgesic agents. Rasayan Journal of Chemistry. 2020; 13(4):2560-2567. ISSN 0974-1496
17. N. Habeela Jainab,, M. K. Mohan Maruga Raja. In Silico Molecular Docking Studies on the Chemical Constituents of Clerodendrum phlomidis for its Cytotoxic Potential against Breast Cancer Markers. Research Journal of Pharmacy and Technology. 2018; 11(4): 1612-1618. doi: 10.5958/0974-360X.2018.00300.1
18. Kumar S, Sharma PP, Shankar U, Kumar D, Joshi SK, Pena L, Durvasula R, Kumar A, Kempaiah P, Poonam, Rathi B. Discovery of new hydroxyethylamine analogs against 3CLproProtein target of SARS-CoV-2: Molecular docking, molecular dynamics simulation, and structure-activity relationship studies. Journal of Chemical Information and Modeling. 2020; 60(12): 5754–5770. https://doi.org/10.1021/acs.jcim.0c00326.
19. Widiandani, T., Purwanto, B. T., and Siswandono The Potency of 4-Nitrobenzoyl-3-Allylthiourea as An Agent of Breast Cancer With Egfr/Her2: In Silico And In Vitro Study. Rasayan Journal of Chemistry. 2022; 15(3): 2083-2088. https://doi.org/10.31788/RJC.2022.1536976
20. Sasikala M, Sundaraganapathy R, Mohan S. MTT Assay on Anticancer Properties of Phytoconstituents from Ipomoea aquatica forsskal using MCF–7 cell lines for breast cancer in Women. Research Journal of Pharmacy and Technology. 2020; 13(3): 1356-1360. doi: 10.5958/0974-360X.2020.00250.4
21. Widiandani, T., Tandian, T., Zufar, B. D., Suryadi, A., Purwanto, B. T., Hardjono, S., and Siswandono, S. In vitro study of pinostrobin propionate and pinostrobin butyrate: Cytotoxic activity against breast cancer cell T47D and its selectivity index. Journal of Public Health in Africa. 2023; 14(s1) https://doi.org/10.4081/jphia.2023.2516
22. Fadilah F, Wiyono L, Edina BC, Rahmawati RA, Erlina L, Tedjo A, Paramita RI. In Silico Study and In Vitro test of Extract Kaempferia pandurata Roxb. as Anti ER (+) Breast Cancer Cell Line MCF-7. Research Journal of Pharmacy and Technology. 2019; 12(5): 2391-2395. doi: 10.5958/0974-360X.2019.00400.1
23. Wiyono L, Edina BC, Rahmawanti RA, Azizah NN, Paramita RI, Purwaningsih EH, Fadilah F. Isolation, Synthesis Nanoparticle, and In-vitro test of Pinostrobin from Kaempferia pandurata on MCF-7 and MDAMB-231 Breast Cancer Cell. Research Journal of Pharmacy and Technology. 2020; 13(6): 2797-2801. doi: 10.5958/0974-360X.2020.00497.7
24. Purwanto, B. T., Siswandono, Kesuma, D., Widiandani, T., and Siswanto, I. Molecular modeling, admet prediction, synthesis and the cytotoxic activity from the novel n-(4-tert-butylphenylcarbamoyl) benzamide against hela. Rasayan Journal of Chemistry. 2021; 14(2): 1341-1350. https://doi.org/10.31788/RJC.2021.1426196
25. Sasikala M, Sundaraganapathy R, Mohan S. MTT Assay on Anticancer Properties of Phytoconstituents from Ipomoea aquatica forsskal using MCF–7 cell lines for breast cancer in Women. Research Journal of Pharmacy and Technology. 2020; 13(3): 1356-1360. doi: 10.5958/0974-360X.2020.00250.4
26. Isrul M., Juliansyah R., Saleh A., Yuliastri W.O, Pusmarani J., Himaniarwati, Maulidina W.O.W. Phytochemical Analysis, Standardization and Cytotoxic Activity of Curcuma aureginosa Extract in Human Breast Cancer (MCF-7) Cell Line. Research Journal of Pharmacy and Technology. 2019;12(4): 1967-1973. doi: 10.5958/0974-360X.2019.00329.9
27. Miguel L.L. Two preclinical tests to evaluate anticancer activity and to help validate drug candidates for clinical trials. Oncoscience. 2015; 2(2): 91–98. https://pubmed.ncbi.nlm.nih.gov/25859551/
28. Ramachandran GN., Ramakrishnan C., and Sasisekharan V. Stereochemistry of Polypeptide Chain Configuration. Journal of Molecular Biology. 1963; 7: 95-99
29. Ruswanto, Mardianingrum R, Lestari T, Nofianti T, Tuslinah L, Nurmalik D. In silico study of the active compounds in bitter melon (Momordica charantia L) as antidiabetic medication. Pharmaciana. 2018; 8(2): 194. https://doi.org/10.12928/pharmaciana.v8i2.8993.
30. Fadilah F, Edina BC, Rahmawati RS, Wiyono L, Erlina L, Paramita RI, dan Tedjo A. 2018. Molecular Dynamics of Pinostrobin and Pinocembrin from Kaempferia pandurata Roxb. towards Estrogen Receptor Positive (ESR) and Estrogen Receptor Negative (VEGFR) of Breast Cancer. Asian Journal of Pharmacy. 2018; 12(S)1473–80.
31. Weerapreeyakul N., Nonpunya A., Barusrux S., Thitimetharoch T., Sripanidkulchai B. 2012. Evaluation of the anticancer potential of six herbs against a hepatoma cell line. Chinese Medicine. 2012; 7(1): 1–7.
32. Nogueira F., Rosário VE. Methods for assessment of antimalarial activity in the different phases of the Plasmodium life cycle. Revista Pan-Amazônica de Saúde. 2010; 1(3): 109–124.
33. Hardjono S, Widiandani T, Purwanto BT, and Anindi L. Molecular Docking of N-benzoyl-N’-(4-fluorophenyl) thiourea Derivatives as Anticancer Drug Candidate and Their ADMET prediction. Research Journal of Pharmacy and Technology. 2019; 12(5): 2160-2166.